Form 4 · Filed Jun 4, 2026, 01:22 AM UTC
AMPH/Amphastar Pharmaceuticals, Inc.
PRINS RICHARD K — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | A | other | 8,143 | $0 | — | 37,598 |
| Jun 1, 2026 | A | other | 17,365 | — | — | 17,365 |
| Aug 19, 2024 | G | other | 1,500 | $0 | — | 29,455 |
Source: SEC EDGAR raw filing ↗ · Accession 0001047579-26-000003